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ABSTRACT 
Triple negative breast cancer (TNBC) is a subtype of breast cancer that is most 
often found in African American females that is characterized by the lack of the 
progesterone receptor (PR), the estrogen receptor (ER), and the human epithelial growth 
factor receptor two (HER2).TNBC is a very aggressive form of breast cancer because it 
does not respond to hormone therapy, due to the lack of the three vital receptors. Since 
the current treatment is not affective, the project used porphyrin to specifically target 
cancer in the body because it has an increased affinity for many cancer types. Gold 
nanorods were used as a way to quickly heat the cells upon irradiation to kill the cells 
with heat. The combination of the porphyrin and gold nanorods was thought to 
selectively target the MDA cells and trigger apoptosis due to hyperthermic ablation once 
exposed to IR irradiation.  
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Objective 
 The objective of this study was to find a localized cancer treatment for triple 
negative breast cancer that does not induce harm on the remaining, noncancerous parts of 
the body. The specific aims of this study were (1) to identify whether gold nanorods 
themselves have a negative impact on the apoptosis rate on triple negative breast cancer 
cells after irradiation, (2) to determine the ideal concentration of gold nanorods to obtain 
the highest level of apoptosis in triple negative breast cancer cells, and (3) to determine 
the ideal time of irradiation to trigger the highest level of apoptosis.   
Background  
According to the National Cancer Institute, breast cancer is defined as a cancer 
that is found in the tissues of the breasts in men and women: tumors are primarily located 
in the ducts and lobules. Although breast cancer can occur in both men and women, it is 
much more commonly found in women. Between the years 2005 and 2009, breast cancer 
affected on average 122 women per 100,000 women in the United States for all races, 
making it the leading cancer incidence in women for those years.[1] There are many 
different types of breast cancer, and they can be classified by examining four different 
characteristics: where they originate from in the breast, the stage of progression of the 
cancer, the presence or absence of the PR, ER and HER2 protein receptors, and their 
morphology. [2] 
MDA-MB-231 is a breast cancer reprises the loss of the progesterone receptor 
(PR), the estrogen receptor (ER), and the human epithelial growth factor receptor two 
(HER2), as found in the triple negative breast cancer (TNBC).[3] TNBC is much more 
difficult to treat than many other types of breast cancer because of the lack of the PR, ER, 
and HER2 protein receptors. Since the current cancer therapies target these receptors, it 
decreases the survival rate in patients with TNBC. TNBC is responsible for 10-15% of all 
breast cancer cases in women.[4] TNBC and basal-like tumors are very similar in their 
demographics. For example, both of the cancers commonly manifest themselves in 
women under the age of 50, and they are more common in African American women 
than any other race. They are also very aggressive types of breast cancer that have 
approximately a 77% survival rate as compared to the 93% survival rate for many other 
breast cancers over a five year period.[5] New therapies are needed to treat TNBC 
effectively.  
Nanotechnology is a scientific research field that utilizes the characteristics, 
behaviors and structures of nanomaterials, particles that are between one and one hundred 
nanometers in size. Nanomaterials generally differ from the element that they are derived 
from. For example, gold nanoshells do not have the same physical properties as gold 
does.[6] Nanomaterials currently have many research and medical applications. For 
example, nanomaterials are used by drug industries in order to attach different ligands 
that transform the nanomaterials into biosensors. One key property of nanomaterials is 
that they can be easily conjugated with ligands, including those that have the potential to 
distinguish between a diseased and normal cell.[6] This characteristic is important because 
of its use in targeting cancerous cells without harming the normal cells in the area, 
significantly reducing side effects of current chemotherapies. By changing the 
morphology of the nanomaterials from spheres to rods, the absorption spectrum will be 
changed from its original wavelength of visible light to a new wavelength of near infrared 
which results in the wavelength infiltrating the human tissues much deeper than before. 
Moreover, Jui-Teng et al and other demonstrate the use of gold nano
photothermal therapy.[7]  
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Figure 1: (Left) The porphyrin conjugated ring system that will attach to the gold nanorods. (Right) The gold nanorods 
that are conjugated to the porphyrin ring system in order to attach to the MDA cells. 
 
Research Plan 
Methods. The process of irradiating MDA-MB-231 cells with conjugated and 
unconjugated gold nanorods is a four-day procedure.  
Cell culture 
The experiment was conducted using MDA-MB-231 cells. They were grown in a 
monolayer using L-15 growth media supplemented with 10% FBS, penicillin and 
streptomycin.  They were maintained without carbon dioxide at 37° C.   
Radiation  
The MDA-MB-231 cells were planted on 96-well plates at a concentration of 
12x104. Four plates were made: one unconjugated gold nanorods with cells without 
radiation, one unconjugated gold nanorods with cells with radiation, one conjugated gold 
nanorods with cells without radiation, and one conjugated gold nanorods with cells with 
radiation. The gold nanorods were added at varying concentrations of 12 µL, 14 µL, 16 
µL and 18 µL, and they were placed in the incubator for one hour. After incubation, the 
wells were washed with PBS. The wells containing MDA-MB-231  cells are then 
irradiated for two minutes per well.  
MTS Assay 
The MTS assay was added to the wells with MDA-MB-231  cells in all four of the 
plates. The four plates were then placed one at a time in the spectrophotometer at 37 C. 
If the average reading for each plate is not 1.2 OD, the plates must continue to be 
incubated until the reading is 1.2 OD.    
Implications  
 The effects of gold nanorods on triple negative breast cancer cells have 
significance towards the development of new treatments for TNBC patients. A localized 
treatment option for aggressive forms of breast cancer could benefit the patients by 
targeting the specific area with cancer and not harming the noncancerous parts of the 
body, reducing side effects. N techniques for the treatment of triple negative breast 
cancer is important in counteracting the high death rate of this type of breast cancer that 
is largely caused by the ineffective treatment with hormonal drugs or monoclonal 
antibodies.[1] 
Results 
The MDA-MB-231 cells were irradiated using a near infrared laser at 785 nm for 
varying times and nanorod concentrations. The project started with a power trail to see 
the optimal decrease in cell viability. Figure 2 shows the percent of cell viability after 
irradiation for 8 minutes at varying powers ranging from 140 to 200 mW. It was 
determined that 140mW yielded the greatest amount of cell death after 8 minutes.  
 Figure 2: The percent of cell viability of the MDA-MB-231 cells irradiated for 8 minutes at varying powers ranging 
from 140 to 200 mW. 
 After the power that had the greatest cell death was determined. The MDA-MB-
231, trials were done to compare the percent of cell death of MDA-MB-231 cells with 
and without radiation. It was hypothesized that the porphyrin would target the MDA-MB-
231 cells and that the gold nanorods would yield a greater amount of concentration heat 
to the cells in order to trigger cell death. Figure 3 demonstrates the similarity between the 
conjugated MDA-MB-231 cells that have been irradiated and those that have not been 
exposed to radiation.  The graph illustrates that cell death was not triggered in either the 
conjugated MDA-MB-231 cells with radiation or those without radiation. The conjugated 
MDA-MB-231 cells that were exposed to radiation should have shown increased cell 
death because of the gold nanorods concentration the heat on the cells. Since the graph 
illustrates that there is not a significant difference between the two conditions, it could 
signify that the gold nanorods were not attached to the conjugated MDA-MB-231 cells. 
Figure 3 was compared with Figure 4 to see if there was a difference in cell viability 
between the conjugated MDA-MB-231 cells and the unconjugated MDA-MB-231 cells. 
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The conjugated MDA-MB-231 cells were exposed to porphyrin and the unconjugated 
were not exposed to porphyrin. In theory, the conjugated MDA-MB-231 cells should 
have had more cell death because the porphyrin should have shown affinity for the MDA-
MB-231 cells. However the graphs showed that there was 0% cell death in both the 
conjugated and unconjugated cells,  
 
Figure 3: MDA-MB-231 cells. Cell viability after treatment with conjugated gold nanorods with and without radiation. 
 
Figure 4: MDA-MB-231 cells. Cell viability after treatment with unconjugated gold nanorods with and without 
radiation. 
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The optimal concentration of gold nanorods was then determined by varying the 
concentrations of conjugated and unconjugated nanorods in MDA-MB-231 cells. The 
concentrations of the unconjuated nanorods ranged from 0.00945 nM to 0.01431 nM. 
While the concentrations of conjugated nanorods varied from 0.0096 nM to 0.0144 nM. 
Although this is a slight difference between the concentrations of nanorods between the 
conjugated and the unconjugated MDA-MB-231 cells, it should not have been significant 
enough to drastically change the percent of cell viability. Both of the graphs showed that 
the greatest amount of apoptosis occurred around 0.01134 nM in unconjugated MDA-
MB-231 cells to 0.0112 nM in conjugated MDA-MB-231 cells that were irradiated.  
 
Figure 5: MDA-MB-231 cells. Cell viability at varying concentrations of unconjugated nanorods.  
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 Figure 6: MDA-MB-231 cells. Cell viability at varying concentrations of conjugated nanorods.  
Discussion 
 At the start of the experiment, a power trail was done in order to find the power 
that yielded the largest percentage of cell death. The trail concluded that for MDA-MB-
231 cells, the optimal power was 140 mW. Trials were done with MDA-MB-231 cells at 
varying concentrations of gold nanorods to find the concentration that caused the most 
cell death. The trails were done with conjugated and unconjugated gold nanorods. Two 
plates were exposed to radiation and the other two were not irradiated. The results from 
the conjugated nanorods showed that a concentration of 0.0112 nM killed the most 
MDA-MB-231 cells. A concentration of 0.01134 nM triggered the most cell death in the 
unconjugated nanorods. The results of the trials were then compared to determine if the 
porphyrin was able to bind to the MDA-MB-231 cells for a specific treatment.  
 The project was not successfully completed in the allotted time due to many 
reasons. The first probable reason for the failure of the project was the inappropriate laser 
capacity in the Chemistry Department. The project relied on the laser being able to 
generate enough heat to irradiate the targeted cells by increasing the energy in the 
0
20
40
60
80
100
120
140
160
180
200
0 0.002 0.004 0.006 0.008 0.01 0.012 0.014 0.016
%
CV
nM
% Cell Viability  MDA-CON-SinRad MDA-CON-Rad
porphyrin conjugated rods. Since the laser was not able to obtain the optimal power 
needed to induce to desired result, it is possible that the cells were not able to receive 
sufficient radiation to trigger apoptosis. Figure 2 demonstrates that varying powers have 
no effect on the cell viability of MDA-MB-231 cells. The most cell death at 140 mW.  
Another possible reason for the failure to induce high levels of apoptosis could be 
attributed to the lack of affinity of the porphyrin conjugated gold nanorods for the MDA-
MB-231. Figure 1 shows the structure of the porphyrin ring that is attached to the gold 
nanorods. The amide to the far left is the portion of the porphyrin ring system that will 
attach to the gold nanorod. Based on the literature, it was believed that the porphyrin rods 
would have an affinity for the MDA-MB-231  cells[8]; however, Figures 3 and 4 implies 
that the porphyrin has little to no affinity for the triple negative breast cancer cells 
because there was close to 100% cell viability after irradiation at 785 nm after incubation 
with the porphyrin nanorods. Additionally when the results from the porphyrin 
conjugated rods were compared to that of the unconjugated rods, there was little 
difference between them, as seen in Figures 3 and 4.  
Both poor laser power and porphyrin’s lack of affinity for MDA-MB-231 cells 
can be seen in Figures 5 and 6. Figure 5 shows the percentage of cell viability of MDA-
MB-231 cells at varying concentrations from 0.00945 to 0.01431 nM. Figure 6 illustrates 
the percentage of cell viability at concentrations ranging from 0.0096 to 0.0144 nM. It 
was expected for the cell viability to decrease as the concentration of gold nanorods 
increased; however, Figures 5 and 6 showed that as the concentration increased, the cell 
viability increased. This either supports that the porphyrin has little to no affinity for 
MDA-MB-231 cells or that the power was not strong enough to induce apoptosis. It 
could also suggest that the gold nanorods are not attaching to the cells, regardless of 
whether the porphyrin is conjugated to the nanorods or not. There is also the possibility 
that the rods aggregated instead of dispersing evenly between the cells. If it is necessary 
for uptake, that could not happen. This would mean that many of the cells were not 
getting the increased heat that the gold nanorods deliver, resulting in greater cell viability.  
Gold nanorods are currently being used in cancer therapy research because they 1) 
have the ability to increase the amount of damage to the cells caused by radiation and 
drugs, and 2) generate heat when exposed to near-infrared radiation, which provides the 
possibility to increase cell death by thermal ablation [13]. Near-infrared light is the best 
type of radiation to use because of its ability to make a way into the deep tissues because 
it is has low levels of absorption by bodily fluids [14]. Gold nanorods are used because 
they are able to decrease the amount of light that results from interactions with 
surrounding tissues. Because they limit the unnecessary light interactions in the 
surrounding tissue areas, gold nanorods also limit the healthy tissue damage as a result of 
radiation [14].  It has been published that cell death will occur when the irradiated sample 
reaches 41°C-47°C using near-infrared light [15]. Hyperthermia results in the denaturing 
of the cellular proteins which weakens the cellular membrane. Its use as a cancer therapy 
is to inhibit tumor cell growth by means of triggering apoptosis in the tumor cells or 
making the cells more susceptible to radiation or chemotherapy [15].   
It is possible that this project was not irradiating the MDA-MB-231 cells long 
enough to reach the necessary temperature to trigger apoptosis, or a more powerful laser 
may have been needed to reach the target temperature range. The cells were irradiated 
using less media in hopes of reaching a higher temperature; however, less media resulted 
in the wells drying too quickly during the irradiation process. It has been suggested that 
the pulsed-mode laser is the more suitable choice for cancer therapies because it allows 
for more efficient photothermal conversion [14]. In the future the research could be 
improved by discovering a way to 1) measure the temperature that irradiation with 
nanorods is giving off compared to samples without nanorods, and 2) achieve the optimal 
temperature without causing greater amount of cell death by stressing the cells due to the 
decreased level of media. The project could also change the type of laser used to the 
pulsed-mode laser in hopes of delivering more efficient and stronger beam to the MDA-
MB-231 cells.  
Conclusion 
Although this experiment did not yield the expected outcome, there is hope for the 
future of localized breast cancer therapies. The particular porphyrin that was chosen for 
use in this experiment is one type among many. In the future, some of the issues with this 
experiment, such as a lack of affinity for the MDA-MB-231 cells by the porphyrin could 
potentially be resolved by using a different type of porphyrin. The other major issue with 
this experiment, the lack of power, could possibly be resolved by using a stronger laser 
with less refraction over a longer period of time, in hopes of increasing the rate of cell 
death.  
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